AstraZeneca PLC Chases Demon Disease Cure, Potential To Be A Blockbuster Drug
Published: Feb 17, 2014
In 1785, the caricaturist Henry William Bunbury declared strong drink, aided by a demon, as the cause of the painful inflammatory disease known as gout. Two hundred years later, AstraZeneca Plc (AZN) may be on the verge of winning approval for a more effective treatment for the malady. Gout is having a resurgence, fueled by increasing rates of obesity and poor diet.
Help employers find you! Check out all the jobs and post your resume.